Julia Fox Said the Quiet Part Loud About Ozempic for Weight Loss: 'There Are Diabetics That Need It'

  • Oops!
    Something went wrong.
    Please try again later.

In the recent months where the use of Ozempic (and it’s alternative brand, off-label siblings semaglutide for (mostly cosmetic) weight loss have been dangerously and uncomfortably normalized, it’s a breath of fresh air to hear someone side-eye the whole deal. Julia Fox (Uncut Gems), who has been battling rumors that she is on the medication, laid out very clearly in a recent interview supporting her Forbidden Fruits podcast why she has no interest in taking it.

“All these people are coming for me saying that I take the weight loss things… people are saying that I’m taking Ozempic or whatever it’s called,” Fox told ET online, noting the very real concerns of taking a medication you don’t need — the harm it does to the people who do need it.

More from SheKnows

“I’m not and I’ve never have… I would never do that,” she said. “There are diabetics that need it.”

As SheKnows has previously reported the uptick in use of these kind of medications by people who they weren’t intended for (people who aren’t diabetic,-pre-diabetic or struggling with insulin resistance) has a direct effect on the people who they were intended for and it leads to a shortage of supply. And all that in pursuit of thinness but under the guise of health? It’s a major red flag.

Click here to read the full article.

“It’s a diabetes medication and there’s people that actually need it,” Fox’s co-host Niki Takesh concluded.

As we see more and more pressure for celebrities to “take the shot” and embrace the rise of Ozempic, it’s a relief to see more and more grown women speaking out and pushing back against the toxicity.

Before you go, check out our favorite quotes to support positive attitudes about food and bodies:

Powerful-quotes-inspire-healthy-attitudes-food
Powerful-quotes-inspire-healthy-attitudes-food

Best of SheKnows

Sign up for SheKnows' Newsletter.
For the latest news, follow us on Facebook, Twitter, and Instagram.